S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
Teva Pharma is the way to play the re-rise of generic drugs
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
Teva Pharma is the way to play the re-rise of generic drugs
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
Teva Pharma is the way to play the re-rise of generic drugs
S&P 500   4,550.43
DOW   35,333.47
QQQ   389.17
Is Microsoft the NVIDIA Killer? 
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Give up the OPEC fight with these 3 stocks, Buffett-certified
AI revolution: 3 stocks set to soar as technology evolves
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
3 reasons a squeeze could be in Paramount's coming attractions
BellRing Brands gets pumped on the Ozempic weight-loss trend
Americans Now Favor Gold Over Stocks as an Investment Vehicle (Ad)
Americans Ditched Big Cities During the Pandemic. Now Many Are Regretting It.
Teva Pharma is the way to play the re-rise of generic drugs

Virios Therapeutics (VIRI) Institutional Ownership

$0.57
-0.03 (-4.96%)
(As of 11/27/2023 ET)
Compare
Today's Range
$0.57
▼
$0.62
50-Day Range
$0.46
▼
$1.07
52-Week Range
$0.22
▼
$2.42
Volume
184,252 shs
Average Volume
928,573 shs
Market Capitalization
$11.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for Virios Therapeutics (NASDAQ:VIRI)

Current
Institutional Ownership
Percentage
10.96%
Number of
Institutional Buyers
(last 12 months)
8
Total
Institutional Inflows
(last 12 months)
$377,728.26
Number of
Institutional Sellers
(last 12 months)
0
Get VIRI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Virios Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

VIRI Institutional Buying and Selling by Quarter


Virios Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2023Citadel Advisors LLC33,298$46K0.0%N/A0.182%
8/14/2023State Street Corp52,828$73K0.0%+397.1%0.289%
8/11/2023Geode Capital Management LLC147,269$0.20M0.0%+144.3%0.805%
8/8/2023Belvedere Trading LLC18,142$25K0.0%N/A0.099%
7/28/2023McCollum Christoferson Group LLC30,700$42K0.0%N/A0.168%
5/16/2023Susquehanna International Group LLP161,811$59K0.0%+343.3%1.943%
5/11/2023Envestnet Asset Management Inc.120,663$44K0.0%+10.5%1.449%
2/13/2023Renaissance Technologies LLC235,400$56K0.0%+33.3%2.826%
2/7/2023Envestnet Asset Management Inc.109,196$26K0.0%+576.3%1.311%
11/14/2022Renaissance Technologies LLC176,600$67K0.0%N/A2.120%
11/7/2022Warberg Asset Management LLC200,000$74K0.0%N/A2.401%
10/13/2022PVG Asset Management Corp80,590$31K0.1%N/A0.967%
8/15/2022State Street Corp10,628$45K0.0%N/A0.128%
7/12/2022Koshinski Asset Management Inc.40,924$0.17M0.0%N/A0.491%
7/6/2022Wiley BROS. Aintree Capital LLC11,000$47K0.0%N/A0.132%
5/16/2022UBS Group AG14,137$63K0.0%+528.3%0.170%
5/13/2022Vanguard Group Inc.241,666$1.08M0.0%+63.4%2.901%
5/12/2022Cetera Advisors LLC43,944$0.20M0.0%+22.0%0.528%
11/16/2021Captrust Financial Advisors40,145$0.21M0.0%N/A0.482%
11/16/2021Cetera Advisors LLC48,432$0.26M0.0%+100.0%0.581%
11/16/2021Masters Capital Management LLC650,000$3.44M0.1%+8.3%7.803%
11/9/2021BlackRock Inc.15,856$84K0.0%+64.3%0.190%
9/17/2021Virtu Financial LLC13,110$82K0.0%N/A0.157%
8/13/2021Geode Capital Management LLC18,499$0.12M0.0%N/A0.222%
8/13/2021Vanguard Group Inc.141,011$0.89M0.0%N/A1.693%
5/18/2021Millennium Management LLC22,858$0.13M0.0%+10.4%0.274%
5/17/2021Masters Capital Management LLC600,000$3.44M0.1%+33.9%7.203%
5/14/2021PVG Asset Management Corp55,160$0.32M1.0%N/A0.662%
5/4/2021Envestnet Asset Management Inc.27,844$0.16M0.0%N/A0.334%
2/24/2021Virtu Financial LLC35,219$0.26M0.0%N/A0.450%
2/17/2021Jane Street Group LLC95,230$0.72M0.0%N/A1.216%
(Data available from 1/1/2016 forward)













VIRI Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of VIRI shares?

During the previous two years, 15 institutional investors and hedge funds held shares of Virios Therapeutics. The most heavily invested institutionals were Vanguard Group Inc. ($1.08M), Geode Capital Management LLC ($0.20M), Cetera Advisors LLC ($0.20M), Koshinski Asset Management Inc. ($0.17M), Warberg Asset Management LLC ($74K), State Street Corp ($73K), and UBS Group AG ($63K).Learn more on VIRI's institutional investors.

What percentage of Virios Therapeutics stock is owned by institutional investors?

10.96% of Virios Therapeutics stock is owned by institutional investors. Learn more on VIRI's institutional investor holdings.

Which institutional investors have been buying Virios Therapeutics stock?

Of the 15 institutional investors that purchased Virios Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Renaissance Technologies LLC ($0.24M), Warberg Asset Management LLC ($0.20M), Susquehanna International Group LLP ($0.13M), Envestnet Asset Management Inc. ($0.10M), Vanguard Group Inc. ($93.80K), Geode Capital Management LLC ($86.98K), and PVG Asset Management Corp ($80.59K).

How much institutional buying is happening at Virios Therapeutics?

Institutional investors have bought a total of 1,133,314 shares in the last 24 months. This purchase volume represents approximately $1.33M in transactions.


Related Companies:
This page (NASDAQ:VIRI) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -